Type(s) of Cancer
Kidney
Kidney
Study Phase
Phase 3
Study Completion Date
August 2015
August 2015
NCT00326898Uploaded 08-19-2017
Access via NCI by Request
PDS UID: nci-data-352
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Files: NCT00326898-D4
Data DictionaryNCT00326898-D4-Data-Dictionary.pdf
DATANCT00326898-D4-Dataset.csv
OTHERREADME.pdf
Files: NCT00326898-D3
Data DictionaryNCT00326898-D3-Data-Dictionary.pdf
DATANCT00326898-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00326898-D2
Data DictionaryNCT00326898-D2-Data-Dictionary.pdf
DATANCT00326898-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00326898-D1
Data DictionaryNCT00326898-D1-Data-Dictionary.pdf
DATANCT00326898-D1-Dataset.csv
OTHERREADME.pdf
Files: NCT00326898-D7
Data DictionaryNCT00326898-D7-Data-Dictionary_2.pdf
DATANCT00326898-D7-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00326898-D5
Data DictionaryNCT00326898-D5-Data-Dictionary_1.pdf
DATANCT00326898-D5-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00326898-D8
Data DictionaryNCT00326898-D8-Data-Dictionary_1.pdf
DATANCT00326898-D8-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00326898-D9
Data DictionaryNCT00326898-D9-Data-Dictionary_1.pdf
DATANCT00326898-D9-Dataset_1.csv
OTHERREADME.pdf